Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cuproptosis-related LncRNAs are potential prognostic and immune response markers for patients with HNSCC via the integration of bioinformatics analysis and experimental validation. | Front Oncol | 2022 | 36620545 | PubTator, text mining | PubMed |
| Cuproptosis related genes associated with Jab1 shapes tumor microenvironment and pharmacological profile in nasopharyngeal carcinoma. | Front Immunol | 2022 | 36618352 | PubTator, text mining | PubMed |
| Targeting Copper in Cancer Imaging and Therapy: A New Theragnostic Agent. | J Clin Med | 2022 | 36615024 | PubTator, text mining | PubMed |
| The Antineoplastic Effect of Carboplatin Is Potentiated by Combination with Pitavastatin or Metformin in a Chemoresistant High-Grade Serous Carcinoma Cell Line. | Int J Mol Sci | 2022 | 36613537 | PubTator, text mining | PubMed |
| Intrinsic and Extrinsic Transcriptional Profiles That Affect the Clinical Response to PD-1 Inhibitors in Patients with Non-Small Cell Lung Cancer. | Cancers (Basel) | 2022 | 36612193 | PubTator, text mining | PubMed |
| Endosomal Sorting Protein SNX27 and Its Emerging Roles in Human Cancers. | Cancers (Basel) | 2022 | 36612066 | PubTator, text mining | PubMed |
| Multi-omics pan-cancer study of cuproptosis core gene FDX1 and its role in kidney renal clear cell carcinoma. | Front Immunol | 2022 | 36605188 | PubTator, text mining | PubMed |
| Prognostic and immune correlation evaluation of a novel cuproptosis-related genes signature in hepatocellular carcinoma. | Front Pharmacol | 2022 | 36588699 | PubTator, text mining | PubMed |
| Identification of Cuproptosis-Related Subtypes in Lung Cancer, Characterization of Tumor Microenvironment Infiltration, and Establishment of a Prognostic Model. | Biomed Res Int | 2022 | 36588537 | PubTator, text mining | PubMed |
| Arterial Tortuosity Syndrome in a Newborn: A Case Report With Literature Review. | Cureus | 2022 | 36578839 | PubTator, text mining | PubMed |
| Identification of a cuproptosis-related lncRNA signature to predict the prognosis and immune landscape of head and neck squamous cell carcinoma. | Front Oncol | 2022 | 36568234 | PubTator, text mining | PubMed |
| Establishment and experimental validation of a novel cuproptosis-related gene signature for prognostic implication in cholangiocarcinoma. | Front Oncol | 2022 | 36568224 | PubTator, text mining | PubMed |
| A comprehensive analysis focusing on cuproptosis to investigate its clinical and biological relevance in uterine corpus endometrial carcinoma and its potential in indicating prognosis. | Front Mol Biosci | 2022 | 36567939 | PubTator, text mining | PubMed |
| Construction and validation of a novel cuproptosis-related long noncoding RNA signature for predicting the outcome of prostate cancer. | Front Genet | 2022 | 36561322 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Association between Human Diseases and Water Pollutants. | Int J Environ Res Public Health | 2022 | 36554354 | PubTator, text mining | PubMed |
| A Combined Risk Score Model to Assess Prognostic Value in Patients with Soft Tissue Sarcomas. | Cells | 2022 | 36552841 | PubTator, text mining | PubMed |
| Cuproptosis-associated genes and immune microenvironment characterization in breast cancer. | Medicine (Baltimore) | 2022 | 36550822 | PubTator, text mining | PubMed |
| Heterogeneous nuclear ribonucleoprotein hnRNPA2/B1 regulates the abundance of the copper-transporter ATP7A in an isoform-dependent manner. | Front Mol Biosci | 2022 | 36545508 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related lncRNAs in the prognosis and therapy response of patients with bladder cancer. | Ann Transl Med | 2022 | 36544685 | PubTator, text mining | PubMed |
| Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis. | Ann Transl Med | 2022 | 36544675 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=32